NUZ 8.11% 20.0¢ neurizon therapeutics limited

Ann: Leiden Testing Indicates MPL SARS-CoV-2 Antiviral Activity, page-222

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 434 Posts.
    lightbulb Created with Sketch. 120
    Thank you Dryasachip. As you state, the timeline says complete manufacture of 10 kg of MPL in Q3 2021 (must be liquid form I guess) and then the timeline says tablet manufacture (smaller dose tablets for human trials) in Q3/Q4 2021.

    So the commencement of the human trials wont be until 2022... which is on schedule...
 
watchlist Created with Sketch. Add NUZ (ASX) to my watchlist
(20min delay)
Last
20.0¢
Change
0.015(8.11%)
Mkt cap ! $98.34M
Open High Low Value Volume
19.0¢ 20.0¢ 19.0¢ $66.44K 346.2K

Buyers (Bids)

No. Vol. Price($)
3 86359 19.0¢
 

Sellers (Offers)

Price($) Vol. No.
20.0¢ 107894 5
View Market Depth
Last trade - 15.42pm 13/11/2024 (20 minute delay) ?
NUZ (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.